Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease

Effectiveness of Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02287935

Enrollment

Registered

2014-11-11

Start date

2009-01-31

Completion date

2014-09-30

Last updated

2014-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Pilonidal Sinus Disease

Keywords

Karydakis procedure, Limberg flap, recurrent pilonidal sinus

Brief summary

It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.

Detailed description

Sacrococcygeal pilonidal sinus is common in young men and may recur overtime after surgery. It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.

Interventions

PROCEDURELimberg flap

Patients were divided into two groups, group 1 were treated with Limberg flap technique (n= 37) . Two groups were compared with a statistical in terms of fluid collection, wound infection, flap edema, hematoma, partial wound separation, return to daily activities, pain score, completes healing time, painless seating and patient satisfactions

PROCEDUREKarydakis procedure

Patients were divided into two groups, group 2 were treated with Karydakis flap (n= 34). Two groups were compared with a statistical in terms of fluid collection, wound infection, flap edema, hematoma, partial wound separation, return to daily activities, pain score, completes healing time, painless seating and patient satisfactions

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

16 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

1. Patients willing to give written informed consent 2. There should be recurrent pilonidal sinus 2\. Recurrent adult patients (over 18 years of age) undergoing surgery for pilonidal sinus 3\. International normalizing ratio (INR) less than 1.5 4\. Prothrombin time (PT) should be less than 15 s 5\. Partial thromboplastin (PTT) time should be near normal 6\. Platelet count should be greater than 50,000 per mm3 to limit the risk of bleeding 7\. There must be no infection at the time of surgery \-

Exclusion criteria

1. Patients not willing to give informed consent 2. Age less than 16 years 3. Patient presenting with conditions mimicking pilonidal sinus 4. Diabetes mellitus, renal failure, immunosuppression e.g. were excluded \-

Design outcomes

Primary

Measure	Time frame	Description
Superiority of Limberg Flap in Recurrent Pilonidal Sinus Disease	January 2009 to December 2013, Patients were invited for control 1 month, 3 months, 6 months, 1 year intervals	Superiority as measured by rates of recurrence and complication, length of hospital stay, return work, VAS skore, patient satisfaction and complet healing duration.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026